Latest Dendreon Stories
WORCESTER, Mass., Feb. 3, 2011 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTC Bulletin Board: GNBT), together with its wholly-owned immunotherapeutic vaccines subsidiary, Antigen Express, Inc.
VANCOUVER, Canada, Jan. 21, 2011 /PRNewswire-Asia/ -- Insiderslab.com issues new research reports that highlight large insider trades found in for Oracle, Hewlett-Packard, State Street, Walt Disney, Aruba, & Dendreon.
SEATTLE, Jan. 7, 2011 /PRNewswire/ -- Dendreon Corporation (Nasdaq: DNDN) today announced several updates regarding the U.S. commercialization of PROVENGEÂ® (sipuleucel-T), the European strategy for PROVENGE, and progress on its pipeline. The Company will host a conference call at 9:00 a.m.
SEATTLE, Jan. 6, 2011 /PRNewswire/ -- Dendreon Corporation (Nasdaq: DNDN) management will host a conference call on Friday, January 7, 2011 at 9:00 a.m. ET to provide updates on U.S.
SAN FRANCISCO, Jan. 6, 2011 /PRNewswire/ -- Vista Partners announced today that it has updated coverage on Opexa Therapeutics, Inc. (Nasdaq: OPXA) and raised its twelve month target price from $4.40 to $6.50.
SEATTLE, Jan. 5, 2011 /PRNewswire/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco on January 10, 2011 at 11:30 a.m. PT.
The promise of vaccines targeted against various types of cancer has raised the hopes of patients and their families.
SEATTLE, Dec. 8, 2010 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the 2010 Deutsche Bank BioFEST conference in Boston on December 15, 2010 at 10:30 a.m. ET.
- One of a pair of round metal cymbals attached to the fingers and struck together for rhythm and percussion in belly dancing.